FDA Inspection 1131413 — Fayz A. Hudefi, M.D.
The FDA completed an inspection of Fayz A. Hudefi, M.D. on September 16, 2020 in Bentonville, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 16, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bentonville, AR (United States)
Additional Details
Clinical Investigator (CI)